Abbott Nutritional Products — Operating Earnings decreased by 19.4% to $311.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 21.1%, from $394.00M to $311.00M. Over 4 years (FY 2021 to FY 2025), Nutritional Products — Operating Earnings shows a downward trend with a -3.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase signals improved profitability and operational performance, while a decrease indicates margin pressure or rising costs.
The profit generated by the nutritional products segment after deducting cost of goods sold and operating expenses, but...
Standard segment operating income metric used by diversified healthcare and consumer goods conglomerates.
abt_segment_nutritional_products_operating_earnings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 490M | 431M | 375M | 251M | 230M | 69M | 156M | 380M | 308M | 284M | 361M | 377M | 373M | 312M | 443M | 394M | 418M | 360M | 386M | 311M |
| QoQ Change | — | -12.0% | -13.0% | -33.1% | -8.4% | -70.0% | +126.1% | +143.6% | -18.9% | -7.8% | +27.1% | +4.4% | -1.1% | -16.4% | +42.0% | -11.1% | +6.1% | -13.9% | +7.2% | -19.4% |
| YoY Change | — | — | — | — | -53.1% | -84.0% | -58.4% | +51.4% | +33.9% | +311.6% | +131.4% | -0.8% | +21.1% | +9.9% | +22.7% | +4.5% | +12.1% | +15.4% | -12.9% | -21.1% |